Related Experiment Video
Updated: Feb 21, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Pathogenicity of Hypertrophic Cardiomyopathy Variants: A Path Forward Together
Jodie Ingles1, Charlotte Burns2, Birgit Funke2
1From the Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia (J.I., C.B.); Sydney Medical School, University of Sydney, Australia (J.I., C.B.); Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia (J.I., C.B.); Department of Pathology, Massachusetts General Hospital, Boston (B.F.); and Harvard Medical School, Boston, MA (B.F.). j.ingles@centenary.org.au.
No abstract available in PubMed .
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Pathophysiology of Heart Failure
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology

